Status:
TERMINATED
Pudendal Assessment in Erectile Dysfunction
Lead Sponsor:
University of Pennsylvania
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18+ years
Brief Summary
The study will address the role of internal pudendal artery disease in erectile dysfunction (ED), and whether it might eventually be amenable to intervention with stenting. There is currently a small ...
Eligibility Criteria
Inclusion
- As above, men with one risk factor for ED such as age\>55, diabetes, hyperlipidemia, smoking, hypertension, coronary disease or peripheral arterial disease
Exclusion
- Patients with ED from a non-arterial cause, including hormonal, neurological, or trauma-related (as determined by past medical history routinely performed prior to catheterization)
- Patients requiring urgent catheterization (e.g. acute coronary syndrome or cardiogenic shock)
- Patients with a creatinine \>1.5 mg/dL and those deemed at increased renal risk (such as from receiving \>200 mL of dye during the primary procedure, post renal transplant or single kidney), as the additional contrast dye required for angiography would pose an undue risk of progressive kidney disease
- Patients with other illnesses that reduce their life expectancy to less than one year
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01262833
Start Date
September 1 2010
End Date
September 1 2013
Last Update
March 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104